The COVID delusion is finished, blown apart |
|
Note: if you are reading this article as an email to my list, you’ll find the links to sources at my blog, where this same article is posted. When we send out emails with too many live links, they tend to get bounced or diverted.
OK, here we go. Smoking gun. Jackpot.
Right from the horse’s mouth. Right from the man we’re told is the number-one COVID expert in the nation. What Fauci says is golden truth.
Well, how about THIS?
July 16, 2020, podcast, “This Week in Virology”: Tony Fauci makes a point of saying the PCR COVID test is useless and misleading when the test is run at “35 cycles or higher.” A positive result, indicating infection, cannot be accepted or believed.
|
|
Read the entire article here:
“Hello, America, you’ve been tricked, lied to, conned, and taken for a devastating ride. On the basis of fake science, the country was locked down.”
Bat Stew Flue is merely a cover for the NWO takeover.
ReplyDeleteImportant to have given this article wider coverage - thanks, Paul. Plus, for the public to know that there are excellent treatments for the CV-19 'thing' already, in such forms as the HCQ cocktail (w/zinc & an antibiotic), or the one w/Budesonide, or the one w/Ivermectin, plus there is Regeneron, as exemplified by Pres. Trump's treatment. The list goes on, of immune system enhancers. This is a scam of immense proportions. DON'T FALL FOR IT, People. It is no more than a seasonal flu, w/both the 'case' rates (w/false positives) and the fatality rates terribly inflated Why? For the NWO crowd's attempt to fasten their totalitarian dream on the whole planet. It's Wakeup time. Thanks for your help in this process, Paul.
ReplyDeleteThen theres this from the CDCs own publication. (No virus isolates available)
ReplyDeleteThis pg 39: https://www.fda.gov/media/134922/download
The analytical sensitivity of the rRT-PCR assays contained in the CDC 2019 Novel Coronavirus (2019-
nCoV) Real-Time RT-PCR Diagnostic Panel were determined in Limit of Detection studies. Since no
quantified virus isolates of the 2019-nCoV are currently available, assays designed for detection of the
2019-nCoV RNA were tested with characterized stocks of in vitro transcribed full length RNA (N gene;
GenBank accession: MN908947.2) of known titer (RNA copies/µL) spiked into a diluent consisting of a
suspension of human A549 cells and viral transport medium (VTM) to mimic clinical specimen
The analytical sensitivity of the rRT-PCR assays contained in the CDC 2019 Novel Coronavirus (2019-
nCoV) Real-Time RT-PCR Diagnostic Panel were determined in Limit of Detection studies. Since no
quantified virus isolates of the 2019-nCoV are currently available, assays designed for detection of the
2019-nCoV RNA were tested with characterized stocks of in vitro transcribed full length RNA (N gene;
GenBank accession: MN908947.2) of known titer (RNA copies/µL) spiked into a diluent consisting of a
suspension of human A549 cells and viral transport medium (VTM) to mimic clinical specimen
The analytical sensitivity of the rRT-PCR assays contained in the CDC 2019 Novel Coronavirus (2019-
nCoV) Real-Time RT-PCR Diagnostic Panel were determined in Limit of Detection studies. Since no
quantified virus isolates of the 2019-nCoV are currently available, assays designed for detection of the
2019-nCoV RNA were tested with characterized stocks of in vitro transcribed full length RNA (N gene;
GenBank accession: MN908947.2) of known titer (RNA copies/µL) spiked into a diluent consisting of a
suspension of human A549 cells and viral transport medium (VTM) to mimic clinical specimen